Sign in

CIK 0001601485 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Elicio Therapeutics, Inc.

Sign in to watch
Ticker
ELTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
113430072
Phone
(857) 209-0050
Business address
451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
Former names
Angion Biomedica Corp.
  1. 8-K Event Results of operations · Exit or restructuring costs
  2. 4 Open-market buy See Remarks bought 277,244 shares at an average $2.63 ($730,373)
  3. 4 Open-market buy See Remarks bought 3,527 shares at $2.54 ($8,976)
  4. 4 Open-market sale See Remarks sold 358 shares at $2.62 ($938)
  5. 4 Open-market buy See Remarks bought 41,625 shares at an average $2.55 ($105,951)
  6. 4 Open-market buy See Remarks bought 77,604 shares at $2.41 ($186,956)
  7. 4 Open-market buy See Remarks bought 4,000 shares at $2.37 ($9,480)
  8. 4 Open-market sale See Remarks sold 451 shares at $2.42 ($1,090)
  9. 4 Open-market sale See Remarks sold 32,118 shares at $3.35 ($107,721)
  10. 4 Open-market sale See Remarks sold 117,882 shares at an average $3.48 ($410,211)
  11. 4 Open-market sale See Remarks sold 374 shares at $4.13 ($1,545)
  12. 4 Open-market sale See Remarks sold 150,000 shares at an average $4.19 ($629,051)
  13. 4 Open-market sale See Remarks sold 433 shares at $4.40 ($1,905)
  14. 8-K Event Results of operations
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. 4 Open-market sale See Remarks sold 373 shares at $8.62 ($3,215)
  18. 4 Open-market sale See Remarks sold 430 shares at $8.65 ($3,720)
  19. 4 Open-market sale See Remarks sold 376 shares at $10.07 ($3,786)
  20. 4 Open-market sale See Remarks sold 430 shares at $10.64 ($4,575)

Page 15 of 20 · 384 filings